{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T10:04:40Z","timestamp":1649066680831},"reference-count":8,"publisher":"Oxford University Press (OUP)","issue":"4","license":[{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,4,1]]},"abstract":"<jats:p>This letter to the editor comments on the recently published article by Flynn et al. about shared decision making as related to discontinuation of tyrosine kinase inhibitors for chronic myeloid leukemia.<\/jats:p>","DOI":"10.1634\/theoncologist.2019-0801","type":"journal-article","created":{"date-parts":[[2020,2,10]],"date-time":"2020-02-10T12:07:53Z","timestamp":1581336473000},"page":"e743-e743","source":"Crossref","is-referenced-by-count":1,"title":["Mistaking the Trees for the Forest?"],"prefix":"10.1093","volume":"25","author":[{"given":"Garth W.","family":"Strohbehn","sequence":"first","affiliation":[{"name":"Section of Hematology and Oncology, The University of Chicago, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher K.","family":"Daugherty","sequence":"additional","affiliation":[{"name":"Section of Hematology and Oncology, The University of Chicago, Chicago, Illinois, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2019,12,24]]},"reference":[{"key":"2021122510232286700_R1","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1634\/theoncologist.2018-0831","article-title":"Exploring patient decision making regarding discontinuation of tyrosine kinase inhibitors for chronic myeloid leukemia","volume":"24","author":"Flynn","year":"2019","journal-title":"The Oncologist"},{"key":"2021122510232286700_R2","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1470-2045(18)30192-X","article-title":"Discontinuation of tyrosine kinase inhibitor therapy in chronic myeloid leukaemia (EURO-SKI): A prespecified interim analysis of a prospective, multicentre, non-randomised, trial","volume":"19","author":"Saussele","year":"2018","journal-title":"Lancet Oncol"},{"key":"2021122510232286700_R3","doi-asserted-by":"crossref","first-page":"e375","DOI":"10.1016\/S2352-3026(19)30094-8","article-title":"De-escalation of tyrosine kinase inhibitor therapy before complete treatment discontinuation in patients with chronic myeloid leukaemia (DESTINY): A non-randomised, phase 2 trial","volume":"6","author":"Clark","year":"2019","journal-title":"Lancet Haematol"},{"key":"2021122510232286700_R4","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1001\/jama.2013.285245","article-title":"Understanding choice: Why physicians should learn prospect theory","volume":"311","author":"Verma","year":"2014","journal-title":"JAMA"},{"key":"2021122510232286700_R5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1353\/cpr.0.0103","article-title":"Applying community-based participatory research principles and approaches in clinical trials: Forging a new model for cancer clinical research","volume":"4","author":"Seifer","year":"2010","journal-title":"Prog Community Health Partnersh"},{"key":"2021122510232286700_R6","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1002\/cncr.27485","article-title":"Patient advocates\u2019 role in clinical trials: Perspectives from Cancer and Leukemia Group B investigators and advocates","volume":"118","author":"Katz","year":"2012","journal-title":"Cancer"},{"key":"2021122510232286700_R7","author":"LegitFrance LOI n\u00b0 2016-41 du 26 janvier 2016 de modernisation de notre systeme de sante"},{"key":"2021122510232286700_R8","first-page":"1","volume-title":"Estimating individual ambiguity aversion: A simple approach. NBER Working Paper no. 20982","author":"Gneezy","year":"2015"}],"container-title":["The Oncologist"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1634\/theoncologist.2019-0801","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1634\/theoncologist.2019-0801","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/25\/4\/e743\/41920438\/oncolo_25_4_e743.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/oncolo\/article-pdf\/25\/4\/e743\/41920438\/oncolo_25_4_e743.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,25]],"date-time":"2021-12-25T10:24:02Z","timestamp":1640427842000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/oncolo\/article\/25\/4\/e743\/6443554"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12,24]]},"references-count":8,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,12,24]]},"published-print":{"date-parts":[[2020,4,1]]}},"URL":"https:\/\/doi.org\/10.1634\/theoncologist.2019-0801","relation":{},"ISSN":["1083-7159","1549-490X"],"issn-type":[{"value":"1083-7159","type":"print"},{"value":"1549-490X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,4,1]]},"published":{"date-parts":[[2019,12,24]]}}}